Double Therapy of Tenofovir and Telbivudine for Elimination of Virus in Patients With Chronic Hepatitis B Virus Infection Awaiting Assisted Reproduction
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 19 May 2017
At a glance
- Drugs Telbivudine (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms tetecait-hbv
- 14 May 2017 Status changed from recruiting to active, no longer recruiting.
- 29 Jul 2016 Planned number of patients changed from 90 to 120.
- 29 Jul 2016 Status changed from active, no longer recruiting to recruiting.